ROLSIGMA Trademark

Trademark Overview

On Tuesday, August 23, 2022, a trademark application was filed for ROLSIGMA with the United States Patent and Trademark Office. The USPTO has given the ROLSIGMA trademark a serial number of 97560126. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, August 21, 2025. This trademark is owned by Minerva Neurosciences, Inc.. The ROLSIGMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
rolsigma

General Information

Serial Number97560126
Word MarkROLSIGMA
Filing DateTuesday, August 23, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, August 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMinerva Neurosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameMinerva Neurosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Friday, August 26, 2022NEW APPLICATION ENTERED
Monday, September 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 15, 2023ASSIGNED TO EXAMINER
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 1 FILED
Tuesday, February 13, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 16, 2024SOU EXTENSION 2 FILED
Thursday, July 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 19, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 19, 2025SOU EXTENSION 3 FILED
Wednesday, February 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 21, 2025SOU EXTENSION 4 GRANTED
Wednesday, February 19, 2025SOU EXTENSION 3 GRANTED
Thursday, August 21, 2025SOU EXTENSION 4 FILED
Thursday, August 21, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

rolsigma pharmaceutical preparations disorder disorders receptors negative mood insomnia symptoms sigma